3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Plasmablastic Lymphoma
1
Lymphoma, T-Cell
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Follicular
1
Hodgkin Disease
1
HIV Infections
1
Burkitt Lymphoma
1
Brain Neoplasms
1
Interventions
Rituximab
16
Cyclophosphamide
10
Lenalidomide
8
venetoclax
7
Magnetic Resonance Spectroscopy
7
obinutuzumab
5
ibrutinib
5
Specimen Handling
5
Prednisone
5
CT-P10
5
fludarabine phosphate
4
fludarabine
4
Whole-Body Irradiation
4
Vincristine
4
Biopsy
4
zanubrutinib
3
orelabrutinib
3
Mycophenolic Acid
3
Doxorubicin
3
Cyclosporine
3
polatuzumab vedotin
2
pirtobrutinib
2
Tacrolimus
2
Peripheral Blood Stem Cell Transplantation
2
Etoposide
2
Busulfan
2
Bendamustine Hydrochloride
2
voruciclib
1
treosulfan
1
tafasitamab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, B-Cell, Marginal Zone
×
carmustine, poliferprosan 20 drug combination
×
90 days
×
Clear all
No trials found.